Clinical Trials Browser

Phase 2 × Multiple Myeloma × Everolimus × Clear all

NCT01234974 2013-01-10

IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus

Phase 2 Withdrawn

Multiple Myeloma

NCT00618345 2011-05-16

Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell